All Biotech News

List of articles in category All Biotech News
Title	Published Date
Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab	05/01/2018
Neurimmune Appoints Fabian Buller as Chief Business Officer	04/26/2018
Orchard Therapeutics Expands US Presence with New Corporate Office in Boston	04/24/2018
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology	04/24/2018
Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells	04/20/2018
ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project	04/18/2018
Vetter Welcomes Illinois Governor Bruce Rauner to its German Facilities	04/17/2018
WACKER Strengthens Its Pharmaceutical-Protein Business and Buys Dutch Biotechnology Plant	04/17/2018
Sartorius Stedim Biotech and Penn State University Announce Partnership	04/16/2018
Oncology Company Hercules Pharmaceuticals to Present AhR Inhibitor Efficacy Results at Upcoming AACR Meeting on Monday April 16	04/13/2018
DNAe to Present New Data and Preview its Blood-to-Result Test for Bloodstream Infection at ECCMID 2018	04/13/2018
Potential of Icosabutate as a Novel Approach to the Treatment of NASH Highlighted in Late-Breaker At The International Liver Congress™ 2018	04/12/2018
GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics	04/12/2018
Aurigene to Present Multiple Programs at the AACR 2018 In Chicago, Illinois: (A) Novel Small Molecule, Oral, Antagonists of CD47-SIRPα Interaction; (B) Novel PRMT5 Inhibitors; (C) Covalent, Selective CDK12 Inhibitors and (D) SMARCA2/4 Degraders	04/11/2018
MIMETAS Secures 20 Million Dollar Series B Financing	04/11/2018
Selvita to Present New Data from Its Oncology Programs at the Upcoming AACR Annual Meeting 2018	04/06/2018
TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal	04/04/2018
TFS International Appoints Dr Andrew Copestake as Chief Commercial Officer	04/03/2018
New Real-World Clinical Practice Data Reinforces the Value of the Oncotype DX Breast Recurrence Score® Test for Patients, Physicians and the Health Care System	03/23/2018
Medtech Company IME Technologies Moves to New and Much Larger R & D And Production Facility in Waalre, The Netherlands	03/23/2018
Vetter Wins 2018 ISPE Facility of the Year Award	03/21/2018
Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment for Breast Cancer Patients in Europe	03/21/2018
Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel	03/21/2018
Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion	03/16/2018
Sartorius Stedim Biotech Launches New ambr® 250 High Throughput Bioreactor System for Perfusion Culture	03/14/2018
Orchard Therapeutics Scientific Founder Prof Donald Kohn Recognized with Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement Award	03/09/2018
ProBioGen and Surface Oncology Sign Second Antibody Manufacturing Program	03/08/2018
Orchard Therapeutics to Present at the Cowen and Company Annual Healthcare Conference	03/06/2018
Judith Heikoop Appointed Managing Director at Biomedical Electro Spinning Company IME Technologies	03/02/2018
ProJect Pharmaceutics Expands Facilities for Formulation and Lyophilization Process Development to Meet Safety Requirements for GMO S2 and BSL-2 Biological Products	02/28/2018

Page 36 of 88